During the past decade, Inland Empire Clinical Trials, LLC conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 4 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 4 clinical trials were completed. i.e. 23.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Inland Empire Clinical Trials, LLC" #1 sponsor was "Amgen" with 2 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Galapagos NV" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Inland Empire Clinical Trials, LLC" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Novo Nordisk A/S" with 2 trials as a collaborator and "DSM Nutritional Products, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Inland Empire Clinical Trials, LLC" are "Hepatic Impairment" (3 trials), "Cirrhosis" (2 trials), "Crohn's Disease" (2 trials), "Hypertension, Portal" (2 trials) and "Non-Alcoholic Fatty Liver Disease" (2 trials). Many other conditions were trialed in "Inland Empire Clinical Trials, LLC" in a lesser frequency.

Most popular intervention types in "Inland Empire Clinical Trials, LLC" are "Drug" (18 trials), "Other" (2 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "BI 685509" (2 trials), "Filgotinib" (2 trials), "Olpasiran" (2 trials) and "AMT-101 (oral)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Inland Empire Clinical Trials, LLC" are 19 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Inland Empire Clinical Trials, LLC". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Inland Empire Clinical Trials, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Inland Empire Clinical Trials, LLC, 7 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".